The purpose of this study is to evaluate the safety and tolerability of C-1101 administered as a single dose, transforaminal epidural injection compared to sterile saline
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
24
C-1101
Placebo
Consano Bio Research Site
Broadmeadow, New South Wales, Australia
RECRUITINGConsano Bio Research Site
Wahroonga, New South Wales, Australia
RECRUITINGConsano Bio Research Site
Melbourne, Victoria, Australia
RECRUITINGIncidence and severity of treatment emergent adverse events (TEAEs)
Time frame: From Day 1 to Week 24
Incidence and severity of adverse events of special interest (AESIs)
Time frame: From Day 1 to Week 24
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.